Jan B. Kuhlmann

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Quantification of 2-, 3-monochloropropanediol fatty acid esters and glycidyl esters in food emulsifiers by GC-MS/MS: an alternative approach.

Quantification of 2-, 3-monochloropropanediol fatty acid esters and glycidyl esters in food emulsifiers by GC-MS/MS: an alternative approach.

Journal: Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment
Published: July 10, 2025

Internal exposure to heat-induced food contaminants in omnivores, vegans and strict raw food eaters: biomarkers of exposure to 2- and 3-monochloropropanediol (urinary excretion) and glycidol (hemoglobin adduct N-2,3-dihydroxypropyl-Val).

Internal exposure to heat-induced food contaminants in omnivores, vegans and strict raw food eaters: biomarkers of exposure to 2- and 3-monochloropropanediol (urinary excretion) and glycidol (hemoglobin adduct N-2,3-dihydroxypropyl-Val).

Journal: Archives of toxicology
Published: July 26, 2024

Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study.

Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study.

Journal: Cancers
Published: August 31, 2020

Urinary Excretion of 2/3-Monochloropropanediol (2/3-MCPD) and 2,3-Dihydroxypropylmercapturic Acid (DHPMA) after a Single High dose of Fatty Acid Esters of 2/3-MCPD and Glycidol: A Controlled Exposure Study in Humans.

Urinary Excretion of 2/3-Monochloropropanediol (2/3-MCPD) and 2,3-Dihydroxypropylmercapturic Acid (DHPMA) after a Single High dose of Fatty Acid Esters of 2/3-MCPD and Glycidol: A Controlled Exposure Study in Humans.

Journal: Molecular nutrition & food research
Published: July 24, 2020

2-Monochloropropanediol (2-MCPD), 3-Monochloropropanediol (3-MCPD), and Glycidol in Infant and Adult/Pediatric Nutritional Formula: Single-Laboratory Validation, First Action 2018.12.

2-Monochloropropanediol (2-MCPD), 3-Monochloropropanediol (3-MCPD), and Glycidol in Infant and Adult/Pediatric Nutritional Formula: Single-Laboratory Validation, First Action 2018.12.

Journal: Journal of AOAC International
Published: April 18, 2019

PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study.

PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study.

Journal: European journal of cancer (Oxford, England : 1990)
Published: November 01, 2017

2- and 3-Monochloropropanediols in paper products and their transfer to foods.

2- and 3-Monochloropropanediols in paper products and their transfer to foods.

Journal: Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment
Published: September 07, 2016

2-Chloro-1,3-propanediol (2-MCPD) and its fatty acid esters: cytotoxicity, metabolism, and transport by human intestinal Caco-2 cells.

2-Chloro-1,3-propanediol (2-MCPD) and its fatty acid esters: cytotoxicity, metabolism, and transport by human intestinal Caco-2 cells.

Journal: Archives of toxicology
Published: June 06, 2014

FOLFIRI and sunitinib as first-line treatment in metastatic colorectal cancer patients with liver metastases--a CESAR phase II study including pharmacokinetic, biomarker, and imaging data.

FOLFIRI and sunitinib as first-line treatment in metastatic colorectal cancer patients with liver metastases--a CESAR phase II study including pharmacokinetic, biomarker, and imaging data.

Journal: International journal of clinical pharmacology and therapeutics
Published: May 08, 2014

Current state of nonsurgical therapies for cholangiocarcinoma.

Current state of nonsurgical therapies for cholangiocarcinoma.

Journal: Hepatic oncology
Published: January 01, 2014

Locoregional therapy for cholangiocarcinoma.

Locoregional therapy for cholangiocarcinoma.

Journal: Current opinion in gastroenterology
Published: January 23, 2013

Analytical approaches for MCPD esters and glycidyl esters in food and biological samples: a review and future perspectives.

Analytical approaches for MCPD esters and glycidyl esters in food and biological samples: a review and future perspectives.

Journal: Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment
Published: October 02, 2012
Showing 1-12 of 14

Last Updated: 09/26/2026